Catalyst Wire Dossier Catalyst Wire Dossier

THR-1442

THR-1442 · Newsoara Biopharma Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for THR-1442, covering 2021-12-16 to 2021-12-16. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy of THR-1442 Compared to Dapagliflozin as Add-on Therapy to Metformin in T2DM [Phase 3]

See pricing